Switch to:

Intra-Cellular Therapies Pre-Tax Income

: $-206.89 Mil (TTM As of Sep. 2020)
View and export this data going back to 2013. Start your Free Trial

Pretax income is the income that a company earns before paying income taxes. Intra-Cellular Therapies's pretax income for the three months ended in Sep. 2020 was $-55.18 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2020 was $-206.89 Mil. Intra-Cellular Therapies's pretax margin was -748.87%.

During the past 8 years, Intra-Cellular Therapies's highest Pretax Margin was -531.05%. The lowest was -242165.57%. And the median was -37514.35%.


Intra-Cellular Therapies Pre-Tax Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Pre-Tax Income Premium Member Only Premium Member Only Premium Member Only -104.79 -115.36 -98.83 -155.13 -147.72

Intra-Cellular Therapies Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Pre-Tax Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.86 -40.58 -47.41 -63.71 -55.18

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Intra-Cellular Therapies Pre-Tax Income Distribution

* The bar in red indicates where Intra-Cellular Therapies's Pre-Tax Income falls into.



Intra-Cellular Therapies Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Intra-Cellular Therapies's Pretax Income for the fiscal year that ended in Dec. 2019 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-154.012+0+0+6.291+0
=-147.72

Intra-Cellular Therapies's Pretax Income for the quarter that ended in Sep. 2020 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-55.936+0+0+0.753+-0.00099999999999767
=-55.18

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2020 was -40.583 (Dec. 2019 ) + -47.407 (Mar. 2020 ) + -63.712 (Jun. 2020 ) + -55.184 (Sep. 2020 ) = $-206.89 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies  (NAS:ITCI) Pre-Tax Income Explanation

Intra-Cellular Therapies's Pretax Margin for the quarter that ended in Sep. 2020 is calculated as

Pretax Margin=Pretax Income/Revenue
=-55.184/7.369
=-748.87%

During the past 8 years, Intra-Cellular Therapies's highest Pretax Margin was -531.05%. The lowest was -242165.57%. And the median was -37514.35%.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies Pre-Tax Income Related Terms


Intra-Cellular Therapies Pre-Tax Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)